Risk of patent foramen ovale for thromboembolic events in all age groups

M A de Belder1, L Tourikis, G Leech

  • 1Department of Cardiological Sciences, St. George's Hospital Medical School, Tooting, London, United Kingdom.

Insights

A patent foramen ovale (PFO) is linked to thromboembolic events, especially in patients without other risk factors. Echocardiography revealed PFO in 26% of patients with events and no risk factors, versus 3.2% in controls.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • A patent foramen ovale (PFO) is a potential risk factor for thromboembolic events.
  • Previous studies suggest a PFO may be present in 20-35% of the general population.

Purpose of the Study:

  • To investigate the association between PFO and thromboembolic events in patients.
  • To compare PFO prevalence in patients with and without recognized risk factors for thromboembolism.

Main Methods:

  • 104 patients with stroke, TIA, or peripheral artery embolus underwent contrast echocardiography.
  • 94 control patients without thromboembolic events also underwent echocardiography.
  • Precordial and transesophageal contrast echocardiography were used for PFO detection.

Main Results:

  • A PFO was detected in 22 patients (21% of group I).
  • PFO prevalence was 26% in patients with events and no risk factors (group Ia), 14% in patients with events and risk factors (group Ib), and 3.2% in controls (group II).
  • The odds of PFO were significantly higher in group Ia versus group II (10:1) and group Ib versus group II (5:1).

Conclusions:

  • PFO is significantly associated with thromboembolic events, particularly in patients without other identifiable risk factors.
  • The study highlights the importance of considering PFO in the etiological workup of thromboembolic events.
  • Lower-than-expected PFO prevalence may be due to patient selection or limitations in echocardiographic detection.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...